clopenthixol has been researched along with Paranoia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goujon, MJ; Murray, GK; Osimo, EF; Perez, J | 1 |
DVORAKOVA, M; JANOVSKY, F; PETROVA, E; SEDIVEC, V; VENCOVSKY, E | 1 |
POELDINGER, W | 2 |
Starr, JM | 1 |
Banshchikov, VM; Romanova, IS; Rozhanets, RV | 1 |
6 other study(ies) available for clopenthixol and Paranoia
Article | Year |
---|---|
Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?
Topics: Adult; Antipsychotic Agents; Clopenthixol; Dopamine Antagonists; Drug Therapy, Combination; Hallucinations; Humans; Male; Olanzapine; Paranoid Disorders; Receptors, Dopamine; Schizophrenia; Treatment Outcome | 2019 |
[PRELIMINARY CLINICAL EXPERIENCES WITH SORDINOL THERAPY].
Topics: Bipolar Disorder; Brain; Catatonia; Clopenthixol; Electrophysiology; Hallucinations; Humans; Mental Disorders; Paranoid Disorders; Psychotic Disorders; Tranquilizing Agents | 1963 |
[CLINICAL EXPERIENCES WITH THE THIAXANTHENE DERIVATIVE CLOPENTHIXOL (SORDINOL) IN PSYCHIATRIC PHARMACOTHERAPY].
Topics: Antisocial Personality Disorder; Clopenthixol; Depression; Humans; Intellectual Disability; Mental Disorders; Paranoid Disorders; Psychotic Disorders; Schizophrenia; Tranquilizing Agents | 1963 |
Treating acquired haemophilia: an ethical conundrum.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Clopenthixol; England; Ethics, Medical; Female; Hemophilia A; Humans; Injections, Intramuscular; Mental Competency; Paranoid Disorders; Risperidone; Treatment Refusal | 2001 |
[Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
Topics: Adult; Chlorprothixene; Clopenthixol; Depression; Female; Humans; Male; Middle Aged; Movement Disorders; Oral Manifestations; Paranoid Disorders; Parasympatholytics; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |
[Use of sordinol in mental disordes of vascular origin].
Topics: Adult; Aged; Cerebrovascular Disorders; Clopenthixol; Delirium; Depression; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Neurocognitive Disorders; Paranoid Disorders; Piperazines; Plethysmography, Impedance; Tranquilizing Agents | 1968 |